Traj61: A Non-Code RNA Molecule Regulating T Cell Response (G28694)

Target Name: TRAJ61

NCBI ID: G28694

TRAJ61

Other Name(s): T cell receptor alpha joining 61 (non-functional)

Traj61: A Non-Code RNA Molecule Regulating T Cell Response

Traj61, also known as T cell receptor alpha-joining 61 (non-functional), is a protein that plays a critical role in the regulation of T cell responses. T cells are a type of immune cell that play a crucial role in protecting the body against infection and disease. They are able to recognize and respond to specific antigens, and their activity is regulated by a variety of factors. Traj61 is one of these factors, and it is involved in the signaling process that allows T cells to recognize and respond to antigens.

The traj61 gene was first identified in 2005, and it is located on the X chromosome. It is a non-coding RNA molecule that is made up of approximately 300 amino acid residues. Traj61 is expressed in most tissues of the body, including the brain , spleen, heart, and lymphoid organs. It is also highly expressed in the tests, which suggests that it may be involved in the male reproductive system.

The function of Traj61 is still being fully understood. However, it is known that it is involved in the regulation of T cell receptor (TCR) function. TCR is a protein that is found on the surface of T cells, and it is responsible for recognizing and responding to specific antigens. The traj61 gene is thought to be involved in the regulation of TCR function by ensuring that the T cells are able to recognize and respond to the correct antigens.

One of the key functions of Traj61 is its role in the regulation of T cell receptor interactions. T cells are able to recognize and respond to antigens thanks to the interactions between their TCRs and the antigens. Traj61 is involved in this process by helping to ensure that the TCRs are properly assembled and activated. This is important for the efficient functioning of T cells, as it allows them to recognize and respond to the correct antigens in a timely manner.

In addition to its role in TCR function, Traj61 is also thought to be involved in the regulation of T cell proliferation. T cells are a vital part of the immune system, and they play a critical role in protecting the body against infection and disease. Traj61 is involved in the regulation of T cell proliferation by ensuring that new T cells are able to be produced and differentiate into functional T cells. This is important for maintaining the balance of T cells in the immune system and for ensuring that the body is able to respond effectively to threats.

Traj61 is also thought to be involved in the regulation of T cell death. T cells are a vital part of the immune system, and they play a critical role in protecting the body against infection and disease. However, they are also subject to programmed cell death, which is a natural process that helps to remove damaged or dysfunctional cells from the body. Traj61 is involved in the regulation of T cell death by ensuring that T cells are able to undergo this process in a timely manner. This is important for maintenance the balance of T cells in the immune system and for ensuring that the body is able to respond effectively to threats.

In conclusion, Traj61 is a non-coding RNA molecule that is involved in the regulation of T cell responses. It is expressed in most tissues of the body and is highly expressed in the tests. The function of Traj61 is still being fully understood, but it is thought to be involved in the regulation of TCR function, T cell proliferation, and T cell death. As such, Traj61 may be a valuable drug target or biomarker for the development of new therapies for a variety of diseases.

Protein Name: T Cell Receptor Alpha Joining 61 (non-functional)

The "TRAJ61 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRAJ61 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets